The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=68055307&loc=d3e2611-110228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Name:	us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Contract Manufacturing Agreement with Endo (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended
	Jun. 17, 2016	May 31, 2014	Mar. 31, 2017	Mar. 31, 2016
Supply Commitment [Line Items]
Impairment charges			$ 813	$ 0
Sumavel DosePro
Supply Commitment [Line Items]
Impairment charges			$ 800
Promissory note \| Working Capital Advance
Supply Commitment [Line Items]
Working capital advance		$ 7,000
Endo Ventures Supply Agreement
Supply Commitment [Line Items]
Initial term of supply agreement	8 years	8 years